Curis, Inc. (CRIS)
0.4071
-0.10
(-19.86%)
USD |
NASDAQ |
Oct 16, 16:00
0.4174
+0.01
(+2.53%)
After-Hours: 20:00
Curis Enterprise Value : -3.780M for Oct. 16, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 16, 2026 | -3.780M |
| October 15, 2026 | -3.583M |
| October 14, 2026 | -3.404M |
| October 13, 2026 | -3.374M |
| October 12, 2026 | -3.319M |
| October 09, 2026 | -3.265M |
| October 08, 2026 | -3.190M |
| October 07, 2026 | -3.137M |
| October 06, 2026 | -3.113M |
| October 05, 2026 | -3.035M |
| October 02, 2026 | -3.007M |
| October 01, 2026 | -2.954M |
| September 30, 2026 | -2.938M |
| September 29, 2026 | -2.957M |
| September 28, 2026 | -2.953M |
| September 25, 2026 | -2.956M |
| September 24, 2026 | -2.859M |
| September 23, 2026 | -2.718M |
| September 22, 2026 | -2.624M |
| September 21, 2026 | -2.674M |
| September 18, 2026 | -2.624M |
| September 17, 2026 | -2.449M |
| September 16, 2026 | -2.390M |
| September 15, 2026 | -2.371M |
| September 14, 2026 | -2.390M |
| Date | Value |
|---|---|
| September 11, 2026 | -2.371M |
| September 10, 2026 | -2.312M |
| September 09, 2026 | -2.234M |
| September 08, 2026 | -2.098M |
| September 04, 2026 | -1.942M |
| September 03, 2026 | -1.903M |
| September 02, 2026 | -1.883M |
| September 01, 2026 | -1.805M |
| August 31, 2026 | -1.669M |
| August 28, 2026 | -1.669M |
| August 27, 2026 | -1.650M |
| August 26, 2026 | -1.572M |
| August 25, 2026 | -1.474M |
| August 24, 2026 | -1.494M |
| August 21, 2026 | -1.494M |
| August 20, 2026 | -1.435M |
| August 19, 2026 | -1.221M |
| August 18, 2026 | -1.260M |
| August 17, 2026 | -1.065M |
| August 14, 2026 | -1.065M |
| August 13, 2026 | -0.9284M |
| August 12, 2026 | -1.318M |
| August 11, 2026 | -0.0708M |
| August 10, 2026 | 2.560M |
| August 07, 2026 | 3.262M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agenus, Inc. | 522.06M |
| Amgen, Inc. | 277.12B |
| Anika Therapeutics, Inc. | 254.23M |
| BioCryst Pharmaceuticals, Inc. | 2.472B |
| Imunon, Inc. | 5.740M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -8.581M |
| Total Expenses (Quarterly) | 8.581M |
| EPS Diluted (Quarterly) | -4.017 |
| Earnings Yield | -3.51K% |
| Normalized Earnings Yield | -7285.88 |